According to Report Linker, the global market for baby products is worth an amazing $7 billion annually, taking into account an estimated 4 million babies born each year (works out to ~$1800/baby/year). Rogers, it would seem, would like to branch into that market.
In partnership with a U.S. biomedical products company, Exmovere Holdings Ltd., Rogers will provide the Exmobaby, a smart-pyjamas that monitor your baby’s vital signs and movement. Using a range of sensors, and powered by a AAA battery, the Exmobaby will measure your baby’s temperature, perform electrocardiograms (ECGs) on your baby to monitor heart rate, and use an accelerometer to detect movement.
The data can be monitored from your mobile devices wirelessly, and Rogers will be the exclusive provider of this service at a cost of $9.99/month. Currently, only evaluation kits are available for retailers that want to carry the product, but the outfits should be available this fall for $149.
While the Exmobaby has yet to be approved by the U.S. Food and Drug Administration, Rogers VP Machine-to-Machine Mansell Nelson told The Canadian Press that Rogers feels the product is safe for use. “We don’t just put our name or association on anything so there is a certain degree of (endorsement), we’re confident it does what it says it’s supposed to do. [Though] we don’t claim to be a group of medical experts either.”